EU to review rare disease drugs market exclusivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EU to review rare disease drugs market exclusivity

Published:2004-08-27 Issue:9 Volume:22 Page:1061-1061
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Sheridan Cormac

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt0904-1061.pdf

Reference7 articles.

1. https://doi.org/nbt0103-6b

2. https://doi.org/nbt76351

3. https://doi.org/nbt880

4. EMEA

5. Eurordis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating and improving orphan drug regulations in Europe: A Delphi policy study;Health Policy;2012-11

2. Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe;Applied Health Economics and Health Policy;2010-09

3. Orphan drug legislation: lessons for neglected tropical diseases;The International Journal of Health Planning and Management;2009-01

4. FDA launches priority vouchers for neglected-disease drugs;Nature Biotechnology;2008-12

5. Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products;British Journal of Clinical Pharmacology;2006-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP